These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Four cases of hepatitis B virus-related fibrosing cholestatic hepatitis treated with lamivudine. Jung S, Lee HC, Han JM, Lee YJ, Chung YH, Lee YS, Kwon Y, Yu E, Suh DJ. J Gastroenterol Hepatol; 2002 Mar; 17(3):345-50. PubMed ID: 11982709 [Abstract] [Full Text] [Related]
3. [Fatal fibrosing cholestatic hepatitis following renal transplantation]. Sprengers D, van Gelder T, Zondervan PE, Niesters HG, Janssen HL, de Man RA. Ned Tijdschr Geneeskd; 2002 Jul 20; 146(29):1380-4. PubMed ID: 12162178 [Abstract] [Full Text] [Related]
5. [Clinical and histological features of fibrosing cholestatic hepatitis]. Zhu Y, Luo K, Yu L. Zhonghua Gan Zang Bing Za Zhi; 2002 Dec 20; 10(6):434-6. PubMed ID: 12502446 [Abstract] [Full Text] [Related]
9. Reactivation of hepatitis and lamivudine therapy in 11 HBsAg-positive renal allograft recipients: a single centre experience. Murakami R, Amada N, Sato T, Orii T, Kikuchi H, Haga I, Ohashi Y, Okazaki H. Clin Transplant; 2006 Dec 20; 20(3):351-8. PubMed ID: 16824154 [Abstract] [Full Text] [Related]
10. Nucleoside analogue therapy in fibrosing cholestatic hepatitis--a case report in an HBsAg positive renal transplant recipient. Brind AM, Bennett MK, Bassendine MF. Liver; 1998 Apr 20; 18(2):134-9. PubMed ID: 9588773 [Abstract] [Full Text] [Related]
11. Discontinuation of lamivudine treatment for hepatitis flare after kidney or heart transplantation in hepatitis B surface antigen-positive patients: A retrospective case series. Huang YW, Liu CJ, Lai MY, Lee PH, Tsai MK, Wang SS, Lai MK, Kao JH. Clin Ther; 2006 Sep 20; 28(9):1327-34. PubMed ID: 17062306 [Abstract] [Full Text] [Related]
15. Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients. Chan TM, Fang GX, Tang CS, Cheng IK, Lai KN, Ho SK. Hepatology; 2002 Nov 20; 36(5):1246-52. PubMed ID: 12395336 [Abstract] [Full Text] [Related]
16. Long-term experience with lamivudine therapy for hepatitis B virus infection after liver transplantation. Ben-Ari Z, Mor E, Shapira Z, Tur-Kaspa R. Liver Transpl; 2001 Feb 20; 7(2):113-7. PubMed ID: 11172394 [Abstract] [Full Text] [Related]
18. Lamivudine is effective for the treatment of reactivation of hepatitis B virus and fulminant hepatic failure in renal transplant recipients. Lee WC, Wu MJ, Cheng CH, Chen CH, Shu KH, Lian JD. Am J Kidney Dis; 2001 Nov 20; 38(5):1074-81. PubMed ID: 11684562 [Abstract] [Full Text] [Related]
19. Lamivudine monoprophylaxis for de novo HBV infection in HBsAg-negative recipients with HBcAb-positive liver grafts. Vizzini G, Gruttadauria S, Volpes R, D'Antoni A, Pietrosi G, Filì D, Petridis I, Pagano D, Tuzzolino F, Santonocito MM, Gridelli B. Clin Transplant; 2011 Nov 20; 25(1):E77-81. PubMed ID: 21039887 [Abstract] [Full Text] [Related]